跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
VENCLYXTO 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
VENCLYXTO 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Approved
STANDARD
VENCLYXTO 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Abbvie Deutschland Gmbh & Co. Kg
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Sep 3, 2025
Approval ID
e069bdd92bbd7314
Company
Abbvie Deutschland Gmbh & Co. Kg
Type
Standard
Approval Details
Approval Id
e069bdd92bbd7314
Drug Cima Aemps Name
VENCLYXTO 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number
161138007IP1
Holder Company Name
Abbvie Deutschland Gmbh & Co. Kg
Marketing Company Name
Orifarm A/S
Holder Company Detail Path
/organization/abbvie-deutschland-gmbh-and-co-kg
Authorization Date
2025-09-03
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
100 mg
Route Of Administration
VÍA ORAL
Prescription Type
Diagnóstico Hospitalario
Commercialized
No
Company Name
Abbvie Deutschland Gmbh & Co. Kg
Company Detail Path
/organization/abbvie-deutschland-gmbh-and-co-kg
Company Information
Pharmaceutical Company Name
AbbVie Deutschland GmbH & Co. KG
Country Name
Germany
City Name
ludwigshafen am rhein,rheinland-pfalz,country_de
Address
Knollstr. 50
Website
http://www.abbvie.de
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Sep 3, 2025
Approval ID
e069bdd92bbd7314
Type
Standard
Back to CIMA-AEMPS Approvals
